P
Pangenomic Health Inc
CNSX:NARA
Pangenomic Health Inc
CNSX:NARA
Price:
0.405
CAD
-14.74%
Market Cap:
CA$5.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
Income Statement
Earnings Waterfall
Pangenomic Health Inc
Pangenomic Health Inc
Income Statement
Pangenomic Health Inc
Pangenomic Health Inc
Currency: CAD
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(4)
|
(5)
|
(4)
|
(12)
|
(12)
|
(12)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(4)
|
(2)
|
(3)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
|
| Research & Development |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(5)
-24%
|
(4)
+20%
|
(12)
-236%
|
(12)
-1%
|
(12)
+5%
|
(3)
+76%
|
(2)
+31%
|
(1)
+32%
|
(1)
+13%
|
(1)
+0%
|
(4)
-238%
|
(2)
+61%
|
(3)
-100%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(3)
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(5)
-24%
|
(12)
-166%
|
(12)
-2%
|
(12)
-1%
|
(12)
+5%
|
(3)
+75%
|
(2)
+28%
|
(4)
-74%
|
(4)
+5%
|
(4)
-8%
|
(4)
-5%
|
(2)
+54%
|
(3)
-85%
|
|
| Net Income | |||||||||||||||
| Income from Continuing Operations |
(4)
|
(5)
|
(12)
|
(12)
|
(12)
|
(12)
|
(3)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(3)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-24%
|
(12)
-166%
|
(12)
-2%
|
(12)
-1%
|
(12)
+5%
|
(3)
+75%
|
(2)
+28%
|
(4)
-74%
|
(4)
+5%
|
(4)
-8%
|
(4)
-5%
|
(2)
+54%
|
(3)
-85%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.09
-12%
|
-10.94
-12 056%
|
-1.24
+89%
|
-1.24
N/A
|
-1.18
+5%
|
-1.49
-26%
|
-1.01
+32%
|
-1.76
-74%
|
-0.54
+69%
|
-0.82
-52%
|
-0.55
+33%
|
-0.13
+76%
|
-0.21
-62%
|
|
Switch to:
Switch to:
See Also
Discover More
